Share Twitter LinkedIn Facebook Email Yasir Khan, MD, UC Irvine Health outlines how early studies show that DOACS may be promising in VTE at the MOASC Spotlight on ASH 2017.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read
